Cargando…
Efficacy of methotrexate therapy in patients with tubal pregnancy and a serum human chorionic gonadotropin level above 10,000 IU/L
OBJECTIVE: To estimate the failure rate of medical treatment and to identify variables associated with treatment failure in patients with tubal pregnancy and an initial serum level of human chorionic gonadotropin (HCG) over 10,000 IU/L. METHODS: The inclusion criteria were tubal pregnancy diagnosed...
Autores principales: | Kim, Kidong, Suh, Dong Hoon, Cheong, Hyun Hoon, Yoon, Sang Ho, Lee, Taek-Sang, No, Jae Hong, Kim, Yong-Beom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Reproductive Medicine
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968255/ https://www.ncbi.nlm.nih.gov/pubmed/24693496 http://dx.doi.org/10.5653/cerm.2014.41.1.33 |
Ejemplares similares
-
Human chorionic gonadotropin value and its change prior to methotrexate treatment can predict the prognosis in ectopic tubal pregnancies
por: Watanabe, Koichi, et al.
Publicado: (2018) -
Pretreatment serum human chorionic gonadotropin cutoff value for medical treatment success with single-dose and multi-dose regimen of methotrexate in tubal ectopic pregnancy
por: Kim, Junhwan, et al.
Publicado: (2017) -
Trophoblastic Infiltration in Tubal Pregnancy Evaluated by Immunohistochemistry and Correlation with Variation of Beta-Human Chorionic Gonadotropin
por: Ferreira, Danyelle Farias, et al.
Publicado: (2014) -
Protist 10,000 Genomes Project
por: Miao, Wei, et al.
Publicado: (2020) -
Gefitinib and Methotrexate to Treat Ectopic Pregnancies with a Pre-Treatment Serum hCG 1000–10,000 IU/L: Phase II Open Label, Single Arm Multi-Centre Trial()
por: Skubisz, Monika M., et al.
Publicado: (2018)